Article Information
History
- May 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Reetesh Bose, M.D., B.Sc1,2,*,
- Selam Ogbalidet, B.Sc., B.A.3,
- Mina Boshra, B.Sc.3,
- Alexandra Finstad, B.Sc., B.A.3,
- Barbara Marzario, M.D., B.Sc.1,2,
- Christina Huang, M.D., B.Sc.1,2 and
- Simone Fahim, MD, FRCPC, FAAD1,2,3
- 1University of Ottawa, Division of Dermatology, 737 Parkdale Avenue, Ottawa, ON K1Y 4M9, Canada
- 2The Ottawa Hospital Division of Dermatology, 737 Parkdale Avenue, Ottawa, ON K1Y 4M9, Canada
- 3University of Ottawa Faculty of Medicine, 451 Smyth road, Ottawa, ON, K1H8L1, Canada
- ↵*Corresponding Author: Dr. Reetesh Bose, 737 Parkdale Avenue, Ottawa, ON K1Y 4M9, Canada, Email: reeteshbose{at}gmail.com
Posted May 14, 2021.
Methods for identifying culprit drugs in cutaneous drug eruptions: A scoping review
